Radiotherapy management of rectal cancer in the backdrop of the COVID pandemic.
Cancer Rep (Hoboken)
; 4(2): e1320, 2021 04.
Article
in English
| MEDLINE | ID: covidwho-967725
ABSTRACT
BACKGROUND:
COVID-19 outbreak was declared as a pandemic by the World Health Organization in March 2020. Over the last 3 months, the pandemic has challenged the diagnosis and treatment of all cancer, including rectal cancer. Constraints in resources call for a change in the treatment strategy without compromising efficacy. RECENTFINDINGS:
Delivery of shorter treatment schedules for radiotherapy offers advantages like short overall treatment time, improved throughput on the machine, improved compliance and reduced risk of transmission of COVID 19. Other strategies include delaying surgery, reducing the intensity of chemotherapy and adoption of organ preservation approach.CONCLUSION:
The curative treatment of rectal cancer should not be hindered during the COVID pandemic, and modifications in the multi-modality treatment will help achieve quality care.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Rectal Neoplasms
/
Communicable Disease Control
/
Radiation Oncology
/
Pandemics
/
COVID-19
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Cancer Rep (Hoboken)
Year:
2021
Document Type:
Article
Affiliation country:
Cnr2.1320
Similar
MEDLINE
...
LILACS
LIS